Vertex Pharmaceuticals (VRTX) EBIT Growth (1y) (2010 - 2026)
Vertex Pharmaceuticals (VRTX) EBIT Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 2,150.96% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 145.20% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 1,386.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 80.62% |
| Dec 31, 2025 | 17.53% |
| Sep 30, 2025 | 6.26% |
| Jun 30, 2025 | 132.75% |
| Mar 31, 2025 | -44.70% |
| Dec 31, 2024 | 3.79% |
| Sep 30, 2024 | 7.53% |
| Jun 30, 2024 | -442.43% |
| Mar 31, 2024 | 46.28% |
| Dec 31, 2023 | -4.35% |
| Sep 30, 2023 | -7.86% |
| Jun 30, 2023 | -7.22% |
| Mar 31, 2023 | -25.16% |
| Dec 31, 2022 | 17.75% |
| Sep 30, 2022 | 6.85% |
| Jun 30, 2022 | 3,019.00% |
| Mar 31, 2022 | 17.24% |
| Dec 31, 2021 | 17.69% |
| Sep 30, 2021 | 56.86% |
| Jun 30, 2021 | -105.28% |